Follow
Antonio Dans
Antonio Dans
College of Medicine, University of the Philippines
Verified email at up.edu.ph
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
74111*2016
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
176102004
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
176102004
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
166572004
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ...
The Lancet 376 (9735), 112-123, 2010
43062010
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
New England Journal of Medicine 364 (9), 806-817, 2011
32572011
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
22202017
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ...
The lancet 388 (10046), 761-775, 2016
19692016
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis†…
L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ...
The Lancet 376 (9745), 975-983, 2010
12832010
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort†…
S Yusuf, P Joseph, S Rangarajan, S Islam, A Mente, P Hystad, M Brauer, ...
The Lancet 395 (10226), 795-808, 2020
11742020
Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical†…
LA Linkins, AL Dans, LK Moores, R Bona, BL Davidson, S Schulman, ...
Chest 141 (2), e495S-e530S, 2012
10982012
Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S Ounpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
Lancet 364 (9438), 937-52, 2004
1013*2004
Dronedarone in high-risk permanent atrial fibrillation
SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ...
New England Journal of Medicine 365 (24), 2268-2276, 2011
7932011
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P Lůpez-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
7722016
Urinary sodium and potassium excretion and risk of cardiovascular events
MJ O'Donnell, S Yusuf, A Mente, P Gao, JF Mann, K Teo, M McQueen, ...
Jama 306 (20), 2229-2238, 2011
6822011
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
AL Dans, SJ Connolly, L Wallentin, S Yang, J Nakamya, M Brueckmann, ...
Circulation 127 (5), 634-640, 2013
6652013
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ...
New England Journal of Medicine 374 (21), 2032-2043, 2016
4522016
Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study
M Dehghan, A Mente, S Rangarajan, P Sheridan, V Mohan, R Iqbal, ...
The Lancet 392 (10161), 2288-2297, 2018
387*2018
Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin
P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly, L Dyal, ...
Gastroenterology 157 (3), 682-691. e2, 2019
3692019
The rise of chronic non-communicable diseases in southeast Asia: time for action
A Dans, N Ng, C Varghese, ES Tai, R Firestone, R Bonita
The Lancet 377 (9766), 680-689, 2011
3682011
The system can't perform the operation now. Try again later.
Articles 1–20